Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Anesthesia, Local with Sedation : Article by

Quick Find
Authors & Editors
Introduction
Preoperative Selection
Monitored Anesthesia Care
Local Anesthesia
Monitored Anesthesia Care - Technique
Alternatives
Medication
References




Patient Education
Click here for patient education.



Author: Michael Mercandetti, MD, MBA, FACS, Consulting Staff, Department of Surgery, Doctors Hospital of Sarasota

Michael Mercandetti is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Ophthalmology, American College of Surgeons, American Society for Laser Medicine and Surgery, American Society of Ophthalmic Plastic and Reconstructive Surgery, Association of Military Surgeons of the US, and Sarasota County Medical Society

Coauthor(s): Adam J Cohen, MD, Assistant Professor, Department of Ophthalmology, Northwestern University Feinberg School of Medicine; Consulting Surgeon, Myers Wyse Center for the Eye; Director, Center for Facial Rejuvenation; Founding Partner, HC Consulting, Inc; Dedra Hern, CRNA, MA, Certified Registered Nurse Anesthestist, Bayfront Medical and Plastic Surgery Centers

Editors: Rick Green, MD, Consulting Staff, Department of Surgery, Division of Plastic Surgery, St John Medical Center of Longview; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Saifee Rashiq, BM BS, MSc (Epid) DA (UK), FRCPC, Associate Professor, Director, Division of Pain Medicine, Department of Anesthesiology and Pain Medicine, University of Alberta, Edmonton, Canada; Nicolas (Nick) G Slenkovich, MD, Practice Director, Colorado Plastic Surgery Center at Swedish Medical Center; Jorge I de la Torre, MD, FACS, Professor of Surgery and Physical Medicine and Rehabilitation, Residency Program Director, Division of Plastic Surgery, University of Alabama at Birmingham; Director, Center for Advanced Surgical Aesthetics

Author and Editor Disclosure

Synonyms and related keywords: anesthesia, local anesthesia, anesthesia with intravenous sedation, intravenous sedation, MAC, monitored anesthesia care, sedation, local anesthetic infiltration, nerve blocks, tumescent technique, minor nerve block, major nerve block, anesthesia with sedation, plastic surgery sedation, outpatient surgery, outpatient procedure, outpatient anesthesia, outpatient sedation, nerve block, amino amides, lidocaine, bupivacaine, prilocaine, mepivacaine, etidocaine, epinephrine, anesthetic toxicity, CNS toxicity, CNS-induced toxicity



Local anesthesia with sedation offers anesthesia personnel and the surgeon great flexibility in tailoring the degree of anesthesia to the needs of the patient. Procedures that once required patients to stay overnight in the hospital are now performed safely in office and outpatient surgical suites.1 The introduction of new anesthetic applications enables patients to undergo lengthy and complex procedures as outpatients and then promptly and safely be discharged home.2 The choice and route of anesthesia administration is paramount to the patient's overall surgical experience. If, upon discharge, the patient is alert, has minimal pain, and has no nausea or vomiting, then the surgical experience was a positive one (Stoelting, 1989).



The 3 modalities of administering anesthetic agents include local anesthesia, monitored anesthesia care (MAC), and general anesthesia via an endotracheal tube or laryngeal mask.

Appropriate patient selection begins with a meticulous medical and surgical history and physical examination. Once the patient has been cleared for anesthesia, the surgeon must determine if the proposed surgery can be performed effectively under MAC or if general anesthesia is necessary.

Another critical factor contributing to the choice of anesthetic modalities to be employed is the patient's attitude and affect. Some patients want to be "asleep" for the duration of the surgery, fearing any pain or the chance of hearing what is being performed during surgery. Other patients have trepidation toward general anesthesia and "having a tube stuck down the throat." If the intravenous (IV) sedation is not going to be deep and the patient is particularly anxious and not cooperative, this combination may prove meddlesome during prolonged surgical procedures. The patient may become restless, requiring more anesthetic agents for a deeper level of sedation than planned. A resultant decrease in respiratory drive and possible compromise of patient safety may occur during the procedure.



Monitored anesthesia care (MAC) combines intravenous sedation with local anesthetic infiltration or nerve blocks.

Procedures such as otoplasty, facelift, blepharoplasty, or liposuction are examples of surgeries routinely performed under MAC. Patients given monitored anesthesia rather than general anesthesia experience fewer incidences of nausea and vomiting and typically can be discharged home safely and quickly.

The primary disadvantages of MAC are the lack of airway control and the threat of aspiration or obstruction. To minimize these risks, the anesthesia personnel must titrate the medications carefully to maintain spontaneous respirations while maintaining an anesthetic depth, allowing the patient to remain comfortable. Careful selection and administration of medications is essential in producing the desired and optimal intraoperative anesthetic effect and postoperative outcomes.



Local anesthesia encompasses infiltration of the operative site, tumescent techniques, and nerve blocks.

A nerve block can be labeled minor if one nerve is affected or major if more than one nerve or conduction in a nerve plexus is impeded.

Local anesthetic agents are usually of the amino amides class and include such agents as lidocaine, bupivacaine, prilocaine, mepivacaine, and etidocaine. The potency, onset of action, and duration of these agents varies. For additional information on the classes of local anesthetics, see Local Anesthetic Agents, Infiltrative Administration.

Anesthetic AgentDosage CeilingDuration of Action
Lidocaine7.0 mg/kg with EPI*
4.5 mg/kg without EPI
30-60 minutes
Bupivacaine225 mg with EPI
175 mg without EPI
 
30-90 minutes
Prilocaine
 
600 mg with EPI
500 mg without EPI
 
30-90 minutes
 
Mepivacaine
 
7.0 mg/kg with EPI45-90 minutes
 
Etidocaine
 
8.0 mg/kg with EPI
6.0 mg/kg without EPI
120-180 minutes
 

*EPI: epinephrine

Depending on the area to be anesthetized, varying techniques can be implemented. For incisional sites, a local anesthetic such as 1% lidocaine with epinephrine (EPI) is ideal for direct injection into the incisional site with rapid onset of the anesthetic effect. For procedures in which flaps are to be elevated, as in a facelift or coronal forehead lift, the incision site is anesthetized as previously mentioned, and the flap area can be infiltrated with a diluted anesthetic such as 0.5% lidocaine with EPI.

For the local anesthetic, 1% lidocaine often is used with 1:200,000 or 1:100,000 EPI. The latter prolongs the anesthetic effect of lidocaine as a result of its vasoconstrictive properties. If more prolonged anesthesia is desired, lidocaine can be mixed with bupivacaine, providing the rapid but shorter lasting anesthesia effect of the former coupled with the slower but prolonged anesthetic effect of the latter.

In tumescent techniques, vastly larger amounts of anesthetic are used, albeit in dilute concentrations. Adipose tissue is suffused via an infusion cannula in the subcutaneous space, with large volumes of diluted lidocaine (0.05-0.1%) and a diluted concentration of EPI (1:1,000,000) for both anesthetic and hemostatic effects. The safety of this technique lies in the fact that the anesthetic concentration is extremely small, allowing large amounts of solution to be used without reaching toxic levels. For example, a mixture of 500 mL of normal saline with 50 mL of 2% lidocaine will result in a concentration of lidocaine of less than 0.2%. In addition, a tissue plane is created that aids in later dissection.

Complications

Complications of local anesthetic agents can manifest as a localized reaction or systemic adverse effects. The most common cause of such sequelae is secondary to accidental intravascular infiltration but systemic conditions also may increase the risk of these untoward effects. Cardiovascular disease, hepatic and renal dysfunction, acid-base abnormalities, and hypoxia can amplify the possibility of anesthetic toxicity. In addition, the very old, very young, and gravid females may respond aberrantly to these agents.

Localized untoward effects include prolonged or permanent paresthesias, anesthesia, and motor weakness. In addition, local vasoconstriction has been reported with resultant necrosis.

Systemic adverse effects can result in angina pectoris, shortness of breath, dysrhythmias, and cardiovascular collapse. Bupivacaine in particular has been associated with decreased cardiac output and hypotension.

Disorientation, auditory and visual hallucinations, and decreased responsiveness, including coma, are possible effects of CNS toxicity. Respiratory and cardiovascular collapse and seizures also may emanate from CNS-induced toxicity.

Rash and other manifestations of allergic reactions (including anaphylaxis) can result from local anesthetic agents. The amino amides are much less likely to cause immune reactions because of their lack of para-aminobenzoic acid (PABA), as compared to the amino esters, which are derivatives of PABA. Some amino amides do contain methylparaben, a structural similar compound to PABA, which may account for the resultant stimulatory immune effect of the amino amides.

Methemoglobinemia can result in respiratory drive irregularity, cyanosis, and graying of the skin. Prilocaine mainly has been linked to this toxic effect as a result of its metabolite acting as an oxidizing agent of hemoglobin.

Remain cognizant of the possibility of local anesthetic reaction to successfully manage these untoward effects. If suspected, the injection should be terminated, the patient's airway should be assessed for patency, and supplemental oxygen should be administered. Vital signs and pulse oximetry should be checked. If the patient is desaturating, an airway should be secured through basic life support protocols. If this proves unsuccessful, intubation and advanced cardiac life support protocols are indicated. If hypotension or dysrhythmias occur, intravenous fluids, vasopressors, and antiarrhythmic drugs should be employed.

Management of CNS toxicity is directed toward control of respiratory drive and halting seizure activity. For more information on anesthetic toxicity, see Toxicity, Local Anesthetics. Benzodiazepines and succinylcholine are the drugs of choice to abort seizure activity and decrease neuromuscular sequelae to facilitate airway control, respectively.



Intravenous sedation may begin after intravenous access is secured, cardiopulmonary monitors are applied, and oxygen is given via nasal cannulae.

Midazolam (Versed), a short acting, water-soluble benzodiazepine, is administered in 1-mg bolus doses for its amnestic and anxiolytic properties. Midazolam, with a 2-hour half-life, has limited cardiovascular effects, allows for expeditious recovery, and has no postoperative sequelae such as nausea and vomiting.

Fentanyl, a rapidly acting narcotic analgesic, can be administered in boluses of 25- to 50-mcg increments for analgesia with little sedative effect. As with all narcotic agents, respiratory function can be depressed, and the patient may experience nausea and emesis.

A 10- to 20-mg bolus of ketamine, which produces dissociated anesthesia, can facilitate tolerance to injection of local anesthetic agents. Serious cardiovascular adverse effects and seizures have been reported along with psychotic reactions and nightmares.

Propofol (Diprivan) is a rapidly acting sedative and hypnotic agent. Propofol has excellent effects with quick patient recovery. Given in 0.5-1 mg/kg injections that are infused slowly prior to the injection of local anesthesia, propofol maintains respiratory drive and allows the patient to tolerate the local anesthetic injections. A propofol infusion, with a starting dose of as low as 25 mcg/kg/min throughout the procedure, can provide smooth and constant anesthesia with the option of "deepening" the patient at stimulating moments by administering boluses of 50 mcg of fentanyl, 10 mg of ketamine, or 10 mg/kg of propofol.

Near the end of surgery, the propofol infusion must be titrated to "lighten" the patient and must be turned off approximately 5 minutes prior to the end of the procedure. At this time, the patient should be awake and following commands appropriately. Upon transfer to the recovery room, intravenous fentanyl (25-50 mcg) or Demerol (12.5-25 mg) may be given for postoperative pain or shivering.

Postoperatively, patients who have undergone monitored anesthesia care (MAC) must be monitored for cardiorespiratory function, bleeding, nausea, and pain. The rapidity of patient recuperation depends on the length and type of procedure and on the type of sedation employed. Another factor may be the overall patient tolerance to anesthetic agents and the ability to metabolize these chemicals for excretion from the body. Concomitant use of other pharmaceutical agents and body habitus can affect the rate of anesthetic metabolism and overall tolerance to these agents.

For example, a patient who weighs 80 kg should receive a maximum dose of 550 mg of lidocaine with epinephrine. If using 2% lidocaine, then the patient should not receive more than 225 mL of this agent. The maximum doses of all anesthetic agents should be committed to memory, allowing for the calculations as shown above. In addition, medications such as the aminoglycosides, succinylcholine, and compounds that reduce liver functions may increase the toxicity of local anesthetic agents.

The patient should be questioned concerning problems with anesthesia in the past. Using local anesthetics sparingly or avoiding certain compounds helps the clinician to avoid toxic adverse effects.



Although monitored anesthesia care (MAC) is a safe method for providing anesthesia, general anesthesia is preferred for lengthy or complex procedures. General anesthesia provides amnesia, analgesia, and muscle relaxation. In addition, the patient's airway is secured with an endotracheal tube or laryngeal mask, and the risk of aspiration or obstruction is minimized. The primary disadvantage of general anesthesia is the increased incidence of nausea and vomiting and the somnolence of patients postoperatively. However, in properly selected patients, local anesthesia with MAC is a safe and effective method of providing anesthesia for operative procedures.



Drug Category: Anesthetic Agents

Drug NameLidocaine (Dilocaine, Octocaine, Xylocaine)
DescriptionAmide local anesthetic used in 1-2% concentration. Inhibits depolarization of type C sensory neurons by blocking sodium channels.
Epinephrine (EPI) prolongs effect and enhances hemostasis (maximum EPI dose 4.5-7 mg/kg).
Adult DoseMaximum cumulative dose: 300 mg of 0.5% (60 mL) for IV regional filtration
Maximum cumulative dose if EPI present: 500 mg (do not administer IV if EPI present)
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity to amide-type local anesthetics; avoid in Adams-Stokes syndrome and Wolf-Parkinson-White syndrome; avoid in severe sinoatrial, atrioventricular (AV), or intraventricular block, if artificial pacemaker not in place
InteractionsCoadministration with cimetidine or beta-blockers increases toxicity of lidocaine; coadministration with procainamide and tocainide may result in additive cardiodepressant action; may increase effects of succinylcholine
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsUse a solution without preservatives; caution in heart failure, hepatic disease, hypoxia, hypovolemia or shock, respiratory-depression and bradycardia; may increase risk of CNS and cardiac side effects in elderly; high plasma concentrations can cause seizures, heart block, and AV conduction abnormalities

Drug NameBupivacaine (Marcaine, Sensorcaine)
DescriptionMay reduce pain by slowing nerve impulse propagation and reducing action potential, which in turn prevents initiation and conduction of nerve impulses
Adult Dose175 mg maximum intralesionally; if EPI present, maximum dose is 225 mg
Pediatric Dose1.25 mg/kg/dose intralesionally
ContraindicationsDocumented hypersensitivity; septicemia, spinal deformities, severe hypertension, and existing neurologic disease
InteractionsMay enhance effects of CNS depressants; coadministration may increase toxicity of MAO inhibitors, TCAs, beta-blockers, vasopressors, and phenothiazines
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsTest a dose and monitor for CNS toxicity, cardiovascular toxicity, and signs of unintended intrathecal administration
Caution with inflammation or sepsis in region of proposed injection; monitor patient's state of consciousness after each injection; caution in hypertension, cerebral vascular insufficiency, peripheral vascular disease or heart block, and arteriosclerotic heart disease

Drug NameMidazolam (Versed)
DescriptionShorter-acting benzodiazepine sedative-hypnotic useful in patients requiring acute and/or short-term sedation. Midazolam is also useful for its amnestic effects.
Adult DoseLoading dose: 0.05-0.2 mg IV over 2 min
Maintenance dose: 1-2 mcg/kg/min IV titrated to effect
Dosing range:0.4-6 IV mcg/kg/min IV
Alternatively,0.07-0.08 mg/kg IM
Pediatric Dose0.1 - 0.15 mg/kg IV over 2-3 min; for more anxious patients, doses up to 0.5 mg/kg used; intranasal dosing may be used for pediatric sedation (up to 2 years of age); doses are 1-2 mg intranasally and limited by volume delivered
ContraindicationsDocumented hypersensitivity; narrow angle glaucoma, preexisting hypotension, and sensitivity to propylene glycol (the diluent) are main contraindications
InteractionsSedative effects of midazolam may be antagonized by theophyllines; narcotics and erythromycin may accentuate sedative effects of midazolam due to decreased clearance
PregnancyD - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
PrecautionsCaution in congestive heart failure, pulmonary disease, renal impairment, and hepatic failure

Drug NameFentanyl citrate (Sublimaze, Duragesic patch)
DescriptionPotent narcotic analgesic with much shorter half-life than morphine sulfate. DOC for conscious sedation analgesia. Ideal for analgesic action of short duration during anesthesia, and immediate postoperative period.
Excellent choice for pain management and sedation with short duration (30-60 min) and easy to titrate. Easily and quickly reversed by naloxone.
After initial dose, subsequent doses should not be titrated more frequently than q3h or q6h thereafter.
When using transdermal dosage form, majority of patients are controlled with 72 h dosing intervals. However, some patients require dosing intervals of 48 h.
Adult DoseEmergency: 0.5-2 mcg/kg/dose IV/IM
Analgesia: 0.5-1 mcg/kg/dose IV/IM q30-60min
Transdermal: Apply 25 mcg/h system q48-72h
Pediatric Dose<2 years: 2-3 mcg/kg/dose IV/IM q30-60min
2-12 years: 1-2 mcg/kg/dose IV/IM q60min
>12 years: Administer as in adults
ContraindicationsDocumented hypersensitivity; hypotension or potentially compromised airway where it would be difficult to establish rapid airway control
InteractionsPhenothiazines may antagonize analgesic effects of opiate agonists; tricyclic antidepressants may potentiate adverse effects of fentanyl when both drugs are used concurrently
PregnancyC - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
PrecautionsCaution in hypotension, respiratory depression, constipation, nausea, emesis, and urinary retention; idiosyncratic reaction, known as chest wall rigidity syndrome, may require neuromuscular blockade in order to increase ventilation

Drug NamePropofol (Diprivan)
DescriptionPhenolic compound unrelated to other types of anticonvulsants. Has general anesthetic properties.
Adult DoseLoading dose: 0.2 mg/kg IV
Maintenance: 0.1-0.2 mg/kg/min (6-12 mg/kg/h) IV
Pediatric DoseNot established; 2-2.8 mg/kg IV recommended
ContraindicationsDocumented hypersensitivity; those who are not mechanically ventilated
InteractionsReduce propofol dose when administered concomitantly with benzodiazepines, opiates, phenothiazines, ethanol, and narcotics; propofol may potentiate neuromuscular blockade of vecuronium; theophylline may weaken effects of propofol, and dose increase may be needed
PregnancyB - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
PrecautionsDo not administer with blood or blood products using the same IV catheter; patients may develop apnea; may experience a decrease in systemic vascular resistance leading to hypotension



  1. Bitar G, Mullis W, Jacobs W, Matthews D, Beasley M, Smith K, et al. Safety and efficacy of office-based surgery with monitored anesthesia care/sedation in 4778 consecutive plastic surgery procedures. Plast Reconstr Surg. Jan 2003;111(1):150-6; discussion 157-8. [Medline].
  2. Cinnella G, Meola S, Portincasa A, Parisi D, Morgese F, Pavone G, et al. Sedation analgesia during office-based plastic surgery procedures: comparison of two opioid regimens. Plast Reconstr Surg. Jun 2007;119(7):2263-70. [Medline].
  3. Badrinath S, Avramov MN, Shadrick M, Witt TR, Ivankovich AD. The use of a ketamine-propofol combination during monitored anesthesia care. Anesth Analg. Apr 2000;90(4):858-62. [Medline].
  4. Biswas S, Bhatnagar M, Rhatigan M, Kincey J, Slater R, Leatherbarrow B. Low-dose midazolam infusion for oculoplastic surgery under local anesthesia. Eye. Aug 1999;13 (Pt 4):537-40. [Medline].
  5. Coyle TT, Helfrick JF, Gonzalez ML, Andresen RV, Perrott DH. Office-based ambulatory anesthesia: Factors that influence patient satisfaction or dissatisfaction with deep sedation/general anesthesia. J Oral Maxillofac Surg. Feb 2005;63(2):163-72. [Medline].
  6. Hasen KV, Samartzis D, Casas LA, Mustoe TA. An outcome study comparing intravenous sedation with midazolam/fentanyl (conscious sedation) versus propofol infusion (deep sedation) for aesthetic surgery. Plast Reconstr Surg. Nov 2003;112(6):1683-9; discussion 1690-1. [Medline].
  7. Ho AM, Chung DC, To EW, Karmakar MK. Total airway obstruction during local anesthesia in a non-sedated patient with a compromised airway. Can J Anaesth. Oct 2004;51(8):838-41. [Medline].
  8. Hogan Q. Local anesthetic toxicity: an update. Reg Anesth. Nov-Dec 1996;21(6 Suppl):43-50. [Medline].
  9. Holas A. Sedation for locoregional anaesthesia. Adv Exp Med Biol. 2003;523:149-59. [Medline].
  10. Katzen LB. Anesthesia, analgesia, and amnesia. In: Cosmetic Oculoplastic Surgery, Eyelid, Forehead, and Facial Techniques. 3rd ed. 1999:67-74.
  11. Kendell J, Wildsmith JA, Gray IG. Costing anaesthetic practice. An economic comparison of regional and general anaesthesia for varicose vein and inguinal hernia surgery. Anaesthesia. Nov 2000;55(11):1106-13. [Medline].
  12. New drugs for local anesthesia and oral sedation. Dent Today. Dec 2004;23(12):48. [Medline].
  13. Nique TA. Introduction: The anesthetic continuum. In: Anesthesia for Facial Plastic Surgery. 1993:1-3.
  14. Potter JK, Finn R, Cillo J. Modified tumescent technique for outpatient facial laser resurfacing. J Oral Maxillofac Surg. Jul 2004;62(7):829-33. [Medline].
  15. Scarborough DA, Herron JB, Khan A, Bisaccia E. Experience with more than 5,000 cases in which monitored anesthesia care was used for liposuction surgery. Aesthetic Plast Surg. Nov-Dec 2003;27(6):474-80. [Medline].
  16. Thorne AC. Local anesthetics. In: Ashton SM, Beasley RW, Thorne CHM, eds. Grabb and Smith's Plastic Surgery. 5th ed. 1997.
  17. Yagiela JA. Recent developments in local anesthesia and oral sedation. Compend Contin Educ Dent. Sep 2004;25(9):697-706; quiz 708. [Medline].

Anesthesia, Local with Sedation excerpt

Article Last Updated: Mar 7, 2008